Unichem Labs' Q2 consolidated results show a net loss of ₹11.89 Cr, primarily due to a ₹58.26 Cr exceptional interest on a settled EU fine. Revenue from operations grew to ₹578.96 Cr. The company divested its Ireland subsidiary for ₹4.00 Cr, acquired Bayshore USA's marketing business, and invested ₹1.05 Cr in Unichem China.